Neuralink

Overview

Neuralink

Sectors

Health, BioTech

Headquarters

Fremont, California, USA

CEO

Elon Musk

Neuralink raised $280.0M in a Series D Valuation at a $19.03 price per share, amounting to a post-money valuation of $5.0B on August 1, 2023. PMI data indicates that Neuralink's shares have been trading at an 125.9% premium to their Series D Valuation based on institutional secondary market activity.

Register today to view the full report, with more in-depth details and analytics

Series D Valuation

Latest funding round

$5.0B

XXXXX

2023-08-01

XX-XX-XXXX

AV Implied Valuation

$11.3B

2024-12-16

AV Implied Valuation

XXXXX

XX-XX-XXXX

Change since Last Round

+125.9%

2023-08-01 ➞ 2024-12-16

Change since Last Round

XXXXX

XX-XX-XXXX

Secondary Activity

Medium

XXXXX

Volume

$159.46M

XXX

(90 day period)

Bid

XXX

Ask

XXX

Bid

$123.78M

Ask

$35.68M

Research

December 16, 2024

Contrary - Neuralink

December 2, 2024

Contrary - Neuralink

November 19, 2024

Contrary - Neuralink

News

December 15, 2024

Elon Musk Revolutionizes Gaming! The Neural Interface You’ve Been Waiting For.

Neuralink aims to revolutionize gaming by enabling mind-controlled interactions, enhancing accessibility, and creating immersive experiences through brain-computer interface technology.

The Economic Times

December 14, 2024

Elon Musk has until Monday to respond to SEC Twitter settlement, source says

The SEC has reopened an investigation into Musk's Neuralink amid scrutiny over safety comments regarding its brain-chip implants.

December 14, 2024

‘…Weaponized institution doing political dirty work’: Elon Musk isn’t happy about SEC investigations over Neuralink

Elon Musk is frustrated with the SEC's re-opened investigation into Neuralink, alleging political motivations and claiming harassment over his company's practices.

Register today to view the full report, with more in-depth details and analytics:

Access the full report

Register today to view the full Neuralink report, with more in-depth details and analytics:

Access the full Neuralink report

Ready to see it in action?

Schedule a demo with one of our experts